Cargando…
Dihydroartemisinin Exerts Its Anticancer Activity through Depleting Cellular Iron via Transferrin Receptor-1
Artemisinin and its main active metabolite dihydroartemisinin, clinically used antimalarial agents with low host toxicity, have recently shown potent anticancer activities in a variety of human cancer models. Although iron mediated oxidative damage is involved, the mechanisms underlying these activi...
Autores principales: | Ba, Qian, Zhou, Naiyuan, Duan, Juan, Chen, Tao, Hao, Miao, Yang, Xinying, Li, Junyang, Yin, Jun, Chu, Ruiai, Wang, Hui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3416848/ https://www.ncbi.nlm.nih.gov/pubmed/22900042 http://dx.doi.org/10.1371/journal.pone.0042703 |
Ejemplares similares
-
Therapeutic effects of dihydroartemisinin and transferrin against glioblastoma
por: Kim, Suk Hee, et al.
Publicado: (2016) -
Dihydroartemisinin: A Potential Natural Anticancer Drug
por: Dai, Xiaoshuo, et al.
Publicado: (2021) -
Evaluation of the Anticancer Activity of a Bile Acid-Dihydroartemisinin Hybrid Ursodeoxycholic-Dihydroartemisinin in Hepatocellular Carcinoma Cells
por: Huang, Tzu-En, et al.
Publicado: (2020) -
Role of transferrin, transferrin receptors, and iron in macrophage listericidal activity
Publicado: (1991) -
Zinc Protoporphyrin-9 Potentiates the Anticancer Activity of Dihydroartemisinin
por: Zhang, Yu, et al.
Publicado: (2023)